目的探讨死亡受体dr5在急性非淋巴细胞白血病(ANL L)细胞中的表达及其临床意义。

AIM to reveal the expression of death receptor 5 (DR5) in the cells of acute non lymphocyte leukemia (ANLL) and its clinical significance.

youdao

目的：探讨我院急性非淋巴细胞性白血病(ANLL)患者的治疗效果及其预后相关因素。

Objective: to investigated the therapy effect and prognosis related factors in the Acute Non-lymphocytic leukemia (ANLL) patients.

youdao

目的了解多中心协作化疗方案(MCP方案)对急性淋巴细胞白血病(all)和非霍奇金淋巴瘤(NHL)患儿肾脏功能的影响。

Objective to investigate the renal damages in children with acute lymphoblastic leukemia (ALL) and non-Hodgkin's lymphoma (NHL) who received the intensive multicenter-protocols (MCP).

youdao